HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.

AbstractBACKGROUND:
Meta-analysis has shown that smokers have significantly increased risks for Alzheimer's disease (AD), and neuroimaging studies showed that smoking alters white matter (WM) structural integrity.
OBJECTIVE:
Herein, we characterize the effects of cigarette smoke (CS) exposures and withdrawal on WM myelin lipid composition using matrix assisted laser desorption and ionization-imaging mass spectrometry (MALDI-IMS).
METHODS:
Young adult male A/J mice were exposed to air (8 weeks; A8), CS (4 or 8 weeks; CS4, CS8), or CS8 followed by 2 weeks recovery (CS8 + R). Frontal lobe WM was examined for indices of lipid and protein oxidation and lipid profile alterations by MALDI-IMS. Lipid ions were identified by MS/MS with the LIPID MAPS prediction tools database. Inter-group comparisons were made using principal component analysis and R-generated heatmap.
RESULTS:
CS increased lipid and protein adducts such that higher levels were present in CS8 compared with CS4 samples. CS8 + R reversed CS8 effects and normalized the levels of oxidative stress. MALDI-IMS demonstrated striking CS-associated alterations in WM lipid profiles characterized by either reductions or increases in phospholipids (phosphatidylinositol, phosphatidylserine, phosphatidylcholine, or phosphatidylethanolamine) and sphingolipids (sulfatides), and partial reversal of CS's inhibitory effects with recovery. The heatmap hierarchical dendrogram and PCA distinguished CS exposure, duration, and withdrawal effects on WM lipid profiles.
CONCLUSION:
CS-mediated WM degeneration is associated with lipid peroxidation, protein oxidative injury, and alterations in myelin lipid composition, including shifts in phospholipids and sphingolipids needed for membrane integrity, plasticity, and intracellular signaling. Future goals are to delineate WM abnormalities in AD using MALDI-IMS, and couple the findings with MRI-mass spectroscopy to improve in vivo diagnostics and early detection of brain biochemical responses to treatment.
AuthorsKavin Nunez, Jared Kay, Alexander Krotow, Ming Tong, Amit R Agarwal, Enrique Cadenas, Suzanne M de la Monte
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 51 Issue 1 Pg. 151-63 ( 2016) ISSN: 1875-8908 [Electronic] Netherlands
PMID26836183 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aldehydes
  • Phospholipids
  • tert-4-hydroxy-2-nonenal
  • 8-epi-prostaglandin F2alpha
  • Dinoprost
Topics
  • Aldehydes (metabolism)
  • Analysis of Variance
  • Animals
  • Dinoprost (analogs & derivatives, metabolism)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Frontal Lobe (pathology)
  • Lipid Metabolism (drug effects)
  • Male
  • Mice
  • Phospholipids (metabolism)
  • Principal Component Analysis
  • Protein Carbonylation
  • Smoking (pathology)
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (methods)
  • Substance Withdrawal Syndrome (metabolism, pathology)
  • White Matter (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: